BDTX
Black Diamond Therapeutics, Inc.$1.98+0.01 (+0.51%)Prev Close$1.96·MCap$113.5M·P/E7.54·Vol416.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
BDTX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | BIOTECH GROWTH N V | 10% Owner | Sell | 5,784,292 | $2.07 | $12.00M10.1% OS | 0 |
| Oct 17, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 400,000 | $2.34 | $934.1K0.7% OS | 0 |
| Jul 5, 2023 | Behbahani Ali | Director | Buy | 1,000,000 | $5.00 | $5.00M1.7% OS | 0 |
| Jun 30, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 1,000,000 | $5.00 | $5.00M1.7% OS | 0 |
| Jun 27, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 1,740,000 | $5.49 | $9.56M3.0% OS | 0 |
| Jun 27, 2023 | Epstein David M. | SEE REMARKS | Sell | 25,000 | $6.70 | $167.5K | 0 |
| Dec 21, 2022 | Ni Fang | SEE REMARKS | Buy | 56,363 | $1.28 | $72.4K | 0 |
| Oct 31, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 99,801 | $2.25 | $224.9K | 0 |
| Oct 27, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 364,652 | $2.02 | $736.2K0.6% OS | 0 |
| Oct 21, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 87,850 | $1.51 | $132.8K | 0 |
| Oct 19, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 131,423 | $1.36 | $179.1K | 0 |
| Jun 29, 2022 | Ni Fang | SEE REMARKS | Buy | 25,000 | $2.44 | $61.0K | 0 |
| Apr 27, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 405,711 | $2.61 | $1.06M0.7% OS | 0 |
| Apr 18, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 300,000 | $3.27 | $980.6K0.5% OS | 0 |
| Apr 12, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 252,556 | $3.48 | $879.8K | 0 |
| May 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $27.42 | $111.8K | 0 |
| May 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $26.64 | $66.6K | 0 |
| Apr 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $25.00 | $102.0K | 0 |
| Apr 5, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $25.54 | $63.8K | 0 |
| Mar 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $26.36 | $107.5K | 0 |
| Mar 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $26.10 | $65.3K | 0 |
BDTX Insider Buying Activity
The following table shows recent insider purchases of Black Diamond Therapeutics, Inc. (BDTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 17, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 400,000 | $2.34 | $934.1K0.7% OS | 0 |
| Jul 5, 2023 | Behbahani Ali | Director | Buy | 1,000,000 | $5.00 | $5.00M1.7% OS | 0 |
| Jun 30, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 1,000,000 | $5.00 | $5.00M1.7% OS | 0 |
| Jun 27, 2023 | BIOTECH GROWTH N V | 10% Owner | Buy | 1,740,000 | $5.49 | $9.56M3.0% OS | 0 |
| Dec 21, 2022 | Ni Fang | SEE REMARKS | Buy | 56,363 | $1.28 | $72.4K | 0 |
| Oct 31, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 99,801 | $2.25 | $224.9K | 0 |
| Oct 27, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 364,652 | $2.02 | $736.2K0.6% OS | 0 |
| Oct 21, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 87,850 | $1.51 | $132.8K | 0 |
| Oct 19, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 131,423 | $1.36 | $179.1K | 0 |
| Jun 29, 2022 | Ni Fang | SEE REMARKS | Buy | 25,000 | $2.44 | $61.0K | 0 |
| Apr 27, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 405,711 | $2.61 | $1.06M0.7% OS | 0 |
| Apr 18, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 300,000 | $3.27 | $980.6K0.5% OS | 0 |
| Apr 12, 2022 | BIOTECH GROWTH N V | 10% Owner | Buy | 252,556 | $3.48 | $879.8K | 0 |
BDTX Insider Selling Activity
The following table shows recent insider sales of Black Diamond Therapeutics, Inc. (BDTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | BIOTECH GROWTH N V | 10% Owner | Sell | 5,784,292 | $2.07 | $12.00M10.1% OS | 0 |
| Jun 27, 2023 | Epstein David M. | SEE REMARKS | Sell | 25,000 | $6.70 | $167.5K | 0 |
| May 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $27.42 | $111.8K | 0 |
| May 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $26.64 | $66.6K | 0 |
| Apr 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $25.00 | $102.0K | 0 |
| Apr 5, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $25.54 | $63.8K | 0 |
| Mar 12, 2021 | Hatzis-Schoch Brent | See Remarks | Sell | 4,078 | $26.36 | $107.5K | 0 |
| Mar 3, 2021 | Roberts Christopher D. | Chief Scientific Officer | Sell | 2,500 | $26.10 | $65.3K | 0 |
BDTX Insiders
Similar Stocks to BDTX
VRTX
Vertex Pharmaceuticals Incorporated
$515.77+0.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$782.89-1.28%
$83.21B
MRNA
Moderna, Inc.
$146.46+7.28%
$57.75B
RVMD
Revolution Medicines, Inc.
$204.10+0.48%
$44.15B
INSM
Insmed Incorporated
$129.20+1.54%
$27.37B
INCY
Incyte Corporation
$122.02-1.03%
$25.69B
UTHR
United Therapeutics Corporation
$497.75-1.21%
$20.70B
NBIX
Neurocrine Biosciences, Inc.
$157.15+0.37%
$15.65B